Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2018-001371-20-FR
EUCTR2018-001371-20-FRActive, not recruitingPhase 1

Study of the role of local treatments on the modulation of the microbiome in psoriatic skin - Microbiome & Psoriasis Study

CHU de Nice0 sites30 target enrollmentStarted: April 11, 2018Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
30
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Inclusion Criteria

  • •1. Patients of both more than 18-year-old sexes having signed and dated a form of information and informed consent.
  • •2. Subject presenting a psoriasis vulgaris with symmetric hurts in size and in severity, located on elbows and\or knees and having a score of severity (PASI)< 10. The hurts will have to have a surface of at least 4 cms ².
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 28
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range 2

Exclusion Criteria

  • •1. Subject presenting a psoriasis in drop(gout), érythrodermique, exfoliatif or pustuleux.
  • •2. Feminine Subject pregnant or breast-feeding.
  • •3. Subject having received a systematic treatment(processing) and having a potential action(share) on the psoriasis vulgaris (ex: phototherapy, cyclosporine, méthotrexate, biotherapics, steroids, or other immunosuppresseurs treatments(processings)) in 2 months preceding the randomization and during all the duration the study.
  • •4. Subject having received a treatment(processing) antibiotic in the previous three months the visit of inclusion
  • •5. Subject having received the topical treatments(processings) (example: corticostéroïdes, tazarotène, analogues of the vitamin D) or neutral emollients in 4 weeks preceding the randomization

Investigators

Similar Trials

Completed
Not Applicable
A study of potentially curative local therapy alone, or preceded by chemotherapy, in the treatment of Stage Ib-IVa cervical carcinomaCervical cancerCancer
ISRCTN79554459Medical Research Council (MRC) (UK)313
Recruiting
Not Applicable
The evaluation of clinical effect of locally delivered minocycline hydrochloride in the surgical treatment of peri-implantitisCertain infectious and parasitic diseases
KCT0002844Yonsei University Health System, Dental Hospital48
Completed
Not Applicable
The evaluation of clinical effect of locally delivered minocycline hydrochloride, doxycycline irrigation, saline irrigation in the treatment of periodontal abscess patients. A Retrospective Study.
KCT0006551Yonsei University Health System, Dental Hospital63
Not yet recruiting
Phase 3
ocal application of multifunctional cocktail is lumbar spine surgery
CTRI/2022/04/041828ICMR
Recruiting
Phase 4
Clinical effects of treatment of complex regional pain syndrome (CRPS) with pulsed electromagnetic fields (PEMF): a double-blind randomized controlled pilot studyG90.5G90.6G90.7Complex regional pain syndrome type IComplex regional pain syndrome type IIComplex regional pain syndrome, other and unspecified type
DRKS00033005niversitätsklinikum Schleswig-Holstein, Campus Kiel50
Microbiome & Psoriasis Study | Clinical Trial